No correlation between plasma levels of vascular endothelial growth factor or its soluble receptor and acute mountain sickness

High Altitude Medicine and Biology

Volumn 12, Issue 4, 2011, Pages 323-327

  Schommer, Kai ^a   Wiesegart, Neele ^a   Dehnert, Christoph ^b   Mairbäurl, Heimo ^a   Bärtsch, Peter ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

High altitude illness; hypoxia; sFlt 1; vascular permeability; VEGF

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ADULT; AEROBIC EXERCISE; ALTITUDE ACCLIMATIZATION; ALTITUDE DISEASE; ARTICLE; BLOOD VESSEL PERMEABILITY; BRAIN EDEMA; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPOXIA; MALE; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; ALTITUDE; ALTITUDE SICKNESS; ANALYSIS OF VARIANCE; ANOXIA; EXERCISE; FEMALE; HUMANS; MALE; MIDDLE AGED; OXYGEN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; YOUNG ADULT;

EID: 84855182966     PISSN: 15270297     EISSN: 15578682     Source Type: Journal    
DOI: 10.1089/ham.2011.1020     Document Type: Article

References (25)

1. Bailey DM, Roukens R, Knauth M, Kallenberg K, Christ S, Mohr A, Genius J, Storch-Hagenlocher B, Meisel F, McEneny J, et al. (2006). Free radical-mediated damage to barrier function is not associated with altered brain morphology in high-altitude headache. J Cereb Blood Flow Metab 26:99-111. (Pubitemid 41818074)
2. Bartsch P, Bailey DM, Berger MM, Knauth M, and Baumgartner RW. (2004). Acute mountain sickness: Controversies and advances. High Alt Med Biol 5:110-124. (Pubitemid 39069613)
3. Bartsch P, Swenson ER, Paul A, Julg B, and Hohenhaus E. (2002). Hypoxic ventilatory response, ventilation, gas exchange, and fluid balance in acute mountain sickness. High Alt Med Biol 3:361-376. (Pubitemid 36305489)
4. Carmeliet P and Collen D. (2000). Molecular basis of angiogen-esis. Role of VEGF and VE-cadherin. Ann NY Acad Sci 902:249-262; discussion 262-264.
5. Dorward DA, Thompson AA, Baillie JK, MacDougall M, and Hirani N. (2007). Change in plasma vascular endothelial growth factor during onset and recovery from acute mountain sickness. Respir Med 101:587-594. (Pubitemid 46209926)
6. Fischer R, Vollmar C, Thiere M, Born C, Leitl M, Pfluger T, and Huber RM. (2004). No evidence of cerebral oedema in severe acute mountain sickness. Cephalalgia 24:66-71. (Pubitemid 38085197)
7. Gunga HC, Kirsch K, Rocker L, Behn C, Koralewski E, Davila EH, Estrada MI, Johannes B, Wittels P, and Jelkmann W. (1999). Vascular endothelial growth factor in exercising humans under different environmental conditions. Eur J Appl Physiol Occup Physiol 79;484-490. (Pubitemid 29201701)
8. Hackett PH and Roach RC. (2001). High-altitude illness. N Engl J Med 345;107-114. (Pubitemid 32634570)
9. Kallenberg K, Bailey DM, Christ S, Mohr A, Roukens R, Menold E, Steiner T, Bartsch P, Knauth M. (2007). Magnetic resonance imaging evidence of cytotoxic cerebral edema in acute mountain sickness. J Cereb Blood Flow Metab 27;1064-1071. (Pubitemid 46659029)
10. Kraus RM, Stallings HW, 3rd, Yeager RC, Gavin TP. (2004). Circulating plasma VEGF response to exercise in sedentary and endurance-trained men. J Appl Physiol 96;1445-1450. (Pubitemid 38392682)
11. Maloney J, Wang D, Duncan T, Voelkel N, and Ruoss S. (2000). Plasma vascular endothelial growth factor in acute mountain sickness. Chest 118;47-52. (Pubitemid 30485488)
12. Nilles E, Sayward H, and D'Onofrio G. (2009). Vascular endo-thelial growth factor and acute mountain sickness. J Emerg Trauma Shock 2:6-9.
13. Oltmanns KM, Gehring H, Rudolf S, Schultes B, Hackenberg C, Schweiger U, Born J, Fehm HL, and Peters A. (2006). Acute hypoxia decreases plasma VEGF concentration in healthy humans. Am J Physiol Endocrinol Metab 290:E434-439. (Pubitemid 43671688)
14. Palma J, Macedonia C, Deuster P, Olsen C, Mozayeni BR, and Crutchfield KE. (2006). Cerebrovascular dynamics and vascular endothelial growth factor in acute mountain sickness. Wilderness Environ Med 17:1-7. (Pubitemid 43375848)
15. Rey S and Semenza GL. (2010). Hypoxia-inducible factor-1-de-pendent mechanisms of vascularization and vascular remodelling. Cardiovasc Res 86:236-242.
16. Roach RC, Maes D, Sandoval D, Robergs RA, Icenogle M, Hinghofer-Szalkay H, Lium D, and Loeppky JA. (2000). Exercise exacerbates acute mountain sickness at simulated high altitude. J Appl Physiol 88:581-585. (Pubitemid 30097102)
17. Roach RCB, Hackett PH, and Oelz O. (1993). The Lake Louise acute mountain sickness scoring system. In Hypoxia and molecular medicine. Sutton JRH, CS, Coates G. ed.; pp. 272-274.
18. Sampson JB, Cymerman A, Burse RL, Maher JT, and Rock PB. (1983). Procedures for the measurement of acute mountain sickness. Aviat Space Environ Med 54:1063-1073. (Pubitemid 14182329)
19. Schneider M, Bernasch D, Weymann J, Holle R, and Bartsch P. (2002). Acute mountain sickness: Influence of susceptibility, preexposure, and ascent rate. Med Sci Sports Exerc 34:1886-1891. (Pubitemid 35440406)
20. Schoch HJ, Fischer S, and Marti HH. (2002). Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain 125:2549-2557. (Pubitemid 35303512)
21. Schommer K, Wiesegart N, Menold E, Haas U, Lahr K, Buhl H, Bartsch P, and Dehnert C. (2010). Training in normobaric hypoxia and its effects on acute mountain sickness after rapid ascent to 4559m. High Alt Med Biol 11:19-25.
22. Schoonman GG, Sandor PS, Nirkko AC, Lange T, Jaermann T, Dydak U, Kremer C, Ferrari MD, Boesiger P, and Baumgartner RW. (2008). Hypoxia-induced acute mountain sickness is asso-ciated with intracellular cerebral edema: A 3 T magnetic resonance imaging study. J Cereb Blood Flow Metab 28:198-206.
23. Tissot van Patot MC, Leadbetter G, Keyes LE, Bendrick-Peart J, Beckey VE, Christians U, and Hackett P. (2005). Greater free plasma VEGF and lower soluble VEGF receptor-1 in acute mountain sickness. J Appl Physiol 98:1626-1629. (Pubitemid 40570769)
24. Walter R, Maggiorini M, Scherrer U, Contesse J, and Reinhart WH. (2001). Effects of high-altitude exposure on vascular en-dothelial growth factor levels in man. Eur J Appl Physiol 85:113-117. (Pubitemid 32684829)
25. Xu F and Severinghaus JW. (1998). Rat brain VEGF expression in alveolar hypoxia: Possible role in high-altitude cerebral edema. J Appl Physiol 85:53-57. (Pubitemid 28334905)